Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription Articles published in Nature Retrieve available abstracts of 60 articles: HTML format

Single Articles

September 2024
1. KWON D
   HIV: how close are we to a vaccine - or a cure?
   Nature. 2024 Sep 2. doi: 10.1038/d41586-024-02840.
   PubMed    
   
   
   August 2024
2. RYU JK, Yan Z, Montano M, Sozmen EG, et al
   Fibrin drives thromboinflammation and neuropathology in COVID-19.
   Nature. 2024 Aug 28. doi: 10.1038/s41586-024-07873.
   PubMed     Abstract available
   
   
   
3. 
   Stunning trial shows twice-yearly shots can prevent HIV infection.
   Nature. 2024 Aug 2. doi: 10.1038/d41586-024-02493.
   PubMed    
   
   
   July 2024
4. MALLAPATY S
   Seventh patient 'cured' of HIV: why scientists are excited.
   Nature. 2024 Jul 26. doi: 10.1038/d41586-024-02463.
   PubMed    
   
   
   March 2024
5. LENHARO M
   Blockbuster obesity drug leads to better health in people with HIV.
   Nature. 2024 Mar 11. doi: 10.1038/d41586-024-00691.
   PubMed    
   
   
   January 2024
6. FU L, Weiskopf EN, Akkermans O, Swanson NA, et al
   HIV-1 capsids enter the FG phase of nuclear pores like a transport receptor.
   Nature. 2024 Jan 24. doi: 10.1038/s41586-023-06966.
   PubMed     Abstract available
   
   
   
7. DICKSON CF, Hertel S, Tuckwell AJ, Li N, et al
   The HIV capsid mimics karyopherin engagement of FG-nucleoporins.
   Nature. 2024 Jan 24. doi: 10.1038/s41586-023-06969.
   PubMed     Abstract available
   
   
   
8. DAM KA, Fan C, Yang Z, Bjorkman PJ, et al
   Publisher Correction: Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.
   Nature. 2024 Jan 19. doi: 10.1038/s41586-024-07082.
   PubMed    
   
   
   December 2023
9. YE T, Jiao Z, Li X, He Z, et al
   Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization.
   Nature. 2023 Dec 13. doi: 10.1038/s41586-023-06809.
   PubMed     Abstract available
   
   
   November 2023
10. DAM KA, Fan C, Yang Z, Bjorkman PJ, et al
    Intermediate conformations of CD4-bound HIV-1 Env heterotrimers.
    Nature. 2023 Nov 22. doi: 10.1038/s41586-023-06639.
    PubMed     Abstract available
    
    
    
11. LI W, Qin Z, Nand E, Grunst MW, et al
    HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes.
    Nature. 2023 Nov 22. doi: 10.1038/s41586-023-06762.
    PubMed     Abstract available
    
    
    
12. LE VOYER T, Parent AV, Liu X, Cederholm A, et al
    Autoantibodies against type I IFNs in humans with alternative NF-kappaB pathway deficiency.
    Nature. 2023 Nov 8. doi: 10.1038/s41586-023-06717.
    PubMed     Abstract available
    
    
    
13. NKENGASONG J, Reid M, Katz IT
    This is how the world finally ends the HIV/AIDS pandemic.
    Nature. 2023;623:907-909.
    PubMed    
    
    
    October 2023
14. 
    Hope rises that a vaccine can shield people with HIV from a deadly threat.
    Nature. 2023 Oct 18. doi: 10.1038/d41586-023-03220.
    PubMed    
    
    
    
15. THADANI NN, Gurev S, Notin P, Youssef N, et al
    Learning from prepandemic data to forecast viral escape.
    Nature. 2023 Oct 11. doi: 10.1038/s41586-023-06617.
    PubMed     Abstract available
    
    
    September 2023
16. MCLAREN PJ, Porreca I, Iaconis G, Mok HP, et al
    Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
    Nature. 2023 Sep 5. doi: 10.1038/s41586-023-06591.
    PubMed    
    
    
    August 2023
17. ZHAO Y, Lu Y, Richardson S, Sreekumar M, et al
    TRIM5alpha restricts poxviruses and is antagonized by CypA and the viral protein C6.
    Nature. 2023 Aug 9. doi: 10.1038/s41586-023-06401.
    PubMed     Abstract available
    
    
    
18. MCLAREN PJ, Porreca I, Iaconis G, Mok HP, et al
    Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
    Nature. 2023 Aug 2. doi: 10.1038/s41586-023-06370.
    PubMed     Abstract available
    
    
    
19. 
    Variation in African genomes linked to control of HIV.
    Nature. 2023 Aug 2. doi: 10.1038/d41586-023-02277.
    PubMed    
    
    
    July 2023
20. AUGUSTO DG, Murdolo LD, Chatzileontiadou DSM, Sabatino JJ Jr, et al
    A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.
    Nature. 2023 Jul 19. doi: 10.1038/s41586-023-06331.
    PubMed     Abstract available
    
    
    May 2023
21. KEN ML, Roy R, Geng A, Ganser LR, et al
    RNA conformational propensities determine cellular activity.
    Nature. 2023 May 17. doi: 10.1038/s41586-023-06080.
    PubMed     Abstract available
    
    
    February 2023
22. GRAHAM F
    Daily briefing: A third person is HIV-free after stem-cell transplant.
    Nature. 2023 Feb 21. doi: 10.1038/d41586-023-00534.
    PubMed    
    
    
    
23. REARDON S
    Third patient free of HIV after receiving virus-resistant cells.
    Nature. 2023 Feb 21. doi: 10.1038/d41586-023-00479.
    PubMed    
    
    
    
24. LI YL, Langley CA, Azumaya CM, Echeverria I, et al
    The structural basis for HIV-1 Vif antagonism of human APOBEC3G.
    Nature. 2023 Feb 8. doi: 10.1038/s41586-023-05779.
    PubMed     Abstract available
    
    
    January 2023
25. LEE JH, Sutton HJ, Cottrell CA, Phung I, et al
    Author Correction: Long-primed germinal centres with enduring affinity maturation and clonal migration.
    Nature. 2023 Jan 30:1. doi: 10.1038/s41586-023-05741.
    PubMed    
    
    
    
26. CHOMONT N
    Silence, escape and survival drive the persistence of HIV.
    Nature. 2023 Jan 4. doi: 10.1038/d41586-022-04492.
    PubMed    
    
    
    
27. CLARK IC, Mudvari P, Thaploo S, Smith S, et al
    HIV silencing and cell survival signatures in infected T cell reservoirs.
    Nature. 2023 Jan 4. doi: 10.1038/s41586-022-05556.
    PubMed     Abstract available
    
    
    
28. SUN W, Gao C, Hartana CA, Osborn MR, et al
    Phenotypic signatures of immune selection in HIV-1 reservoir cells.
    Nature. 2023 Jan 4. doi: 10.1038/s41586-022-05538.
    PubMed     Abstract available
    
    
    December 2022
29. CAO Y, Jian F, Wang J, Yu Y, et al
    Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.
    Nature. 2022 Dec 19. doi: 10.1038/s41586-022-05644.
    PubMed     Abstract available
    
    
    October 2022
30. 
    Laggard rich countries risk slowing the fight against AIDS, malaria and TB.
    Nature. 2022;610:8.
    PubMed    
    
    
    September 2022
31. LEE JH, Sutton HJ, Cottrell CA, Phung I, et al
    Long-primed germinal centres with enduring affinity maturation and clonal migration.
    Nature. 2022 Sep 21. pii: 10.1038/s41586-022-05216.
    PubMed     Abstract available
    
    
    
32. GONSALVES G
    Monkeypox, COVID-19, AIDS: have we progressed so little?
    Nature. 2022;609:443.
    PubMed    
    
    
    August 2022
33. PADMA TV
    Long-lasting HIV prevention drug could be game changer - but who will pay?
    Nature. 2022 Aug 5. pii: 10.1038/d41586-022-02123.
    PubMed    
    
    
    
34. 
    Preventive HIV drug shows urgent need for transparency on pricing.
    Nature. 2022;608:239.
    PubMed    
    
    
    July 2022
35. 
    Small payments to low-income people lead to big drops in HIV deaths.
    Nature. 2022;607:639.
    PubMed    
    
    
    June 2022
36. CAO Y, Yisimayi A, Jian F, Song W, et al
    BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Nature. 2022 Jun 17. pii: 10.1038/s41586-022-04980.
    PubMed     Abstract available
    
    
    
37. SNELLER MC, Blazkova J, Justement JS, Shi V, et al
    Combination anti-HIV antibodies provide sustained virological suppression.
    Nature. 2022 Jun 1. pii: 10.1038/s41586-022-04797.
    PubMed     Abstract available
    
    
    May 2022
38. SHEN Y, Zhou M, Cai D, Filho DA, et al
    CCR5 closes the temporal window for memory linking.
    Nature. 2022 May 25. pii: 10.1038/s41586-022-04783.
    PubMed     Abstract available
    
    
    
39. SURYAWANSHI RK, Chen IP, Ma T, Syed AM, et al
    Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination.
    Nature. 2022 May 18. pii: 10.1038/s41586-022-04865.
    PubMed     Abstract available
    
    
    
40. URAKI R, Kiso M, Iida S, Imai M, et al
    Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2.
    Nature. 2022 May 16. pii: 10.1038/s41586-022-04856.
    PubMed     Abstract available
    
    
    
41. MALEBRANCHE D
    HIV Care Has Improved Dramatically-But Not for Everyone.
    Nature. 2022;605:S24-S25.
    PubMed    
    
    
    April 2022
42. GAEBLER C, Nogueira L, Stoffel E, Oliveira TY, et al
    Prolonged viral suppression with anti-HIV-1 antibody therapy.
    Nature. 2022 Apr 13. pii: 10.1038/s41586-022-04597.
    PubMed     Abstract available
    
    
    
43. KEETON R, Tincho MB, Ngomti A, Baguma R, et al
    Author Correction: T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
    Nature. 2022 Apr 8. pii: 10.1038/s41586-022-04708.
    PubMed    
    
    
    March 2022
44. DEGRACE MM, Ghedin E, Frieman MB, Krammer F, et al
    Defining the risk of SARS-CoV-2 variants on immune protection.
    Nature. 2022 Mar 31. pii: 10.1038/s41586-022-04690.
    PubMed     Abstract available
    
    
    
45. ROBERTS L
    Surge of HIV, tuberculosis and COVID feared amid war in Ukraine.
    Nature. 2022 Mar 15. pii: 10.1038/d41586-022-00748.
    PubMed    
    
    
    
46. LEDFORD H
    Luc Montagnier (1932-2022).
    Nature. 2022;603:223.
    PubMed    
    
    
    February 2022
47. GRAHAM F
    Daily briefing: Woman cleared of HIV after transplant with umbilical-cord blood.
    Nature. 2022 Feb 16. pii: 10.1038/d41586-022-00483.
    PubMed    
    
    
    
48. GRAHAM F
    Daily briefing: Highly virulent HIV variant circulating in Europe.
    Nature. 2022 Feb 4. pii: 10.1038/d41586-022-00362.
    PubMed    
    
    
    
49. GUGLIELMI G
    Highly virulent HIV variant found circulating in Europe.
    Nature. 2022 Feb 3. pii: 10.1038/d41586-022-00317.
    PubMed    
    
    
    
50. 
    Earliest humans, HIV variant and breakthrough COVID.
    Nature. 2022;602:367.
    PubMed    
    
    
    January 2022
51. KEETON R, Tincho MB, Ngomti A, Baguma R, et al
    T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
    Nature. 2022 Jan 31. pii: 10.1038/s41586-022-04460.
    PubMed     Abstract available
    
    
    
52. WANG K, Jia Z, Bao L, Wang L, et al
    Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants.
    Nature. 2022 Jan 28. pii: 10.1038/s41586-022-04466.
    PubMed     Abstract available
    
    
    
53. VIANA R, Moyo S, Amoako DG, Tegally H, et al
    Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.
    Nature. 2022 Jan 7. pii: 10.1038/s41586-022-04411.
    PubMed     Abstract available
    
    
    December 2021
54. CAO Y, Wang J, Jian F, Xiao T, et al
    Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.
    Nature. 2021 Dec 23. pii: 10.1038/s41586-021-04385.
    PubMed     Abstract available
    
    
    
55. VIDAL SJ, Bekerman E, Hansen D, Lu B, et al
    Long Acting Capsid Inhibitor Protects Macaques From Repeat SHIV Challenges.
    Nature. 2021 Dec 7. pii: 10.1038/s41586-021-04279.
    PubMed     Abstract available
    
    
    
56. MSOMI N, Lessells R, Mlisana K, de Oliveira T, et al
    Africa: tackle HIV and COVID-19 together.
    Nature. 2021;600:33-36.
    PubMed    
    
    
    
57. FAUCI A
    Victories against AIDS have lessons for COVID-19.
    Nature. 2021;600:9.
    PubMed    
    
    
    
58. 
    A fatty molecule shows promise for staving off HIV.
    Nature. 2021;600:572.
    PubMed    
    
    
    November 2021
59. GRAHAM F
    Daily briefing: Second person found to have 'naturally' eradicated HIV.
    Nature. 2021 Nov 18. pii: 10.1038/d41586-021-03489.
    PubMed    
    
    
    March 2021
60. MAXMEN A
    Achilles heel spotted for promising HIV-prevention drug.
    Nature. 2021;591:357-358.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.